Courts On Botox Price Negotiations, Grant Terminations, More
A D.C. federal judge handed AbbVie a win on arguments that the Centers for Medicare & Medicaid Services wrongly selected its Botox drug for Medicare price negotiations....To view the full article, register now.
Already a subscriber? Click here to view full article